Should You Buy Bausch + Lomb Corporation Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Bausch + Lomb Corporation (BLCO) occupies a solid middle-ground position with a Quality of Company score of 6.3/10. At the current market price of $17.23, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.
The short answer: 5 of 7 CirclFi valuation models project upside for Bausch + Lomb Corporation (BLCO) at $17.23 — the model consensus leans bullish, with a Quality Score of 6.3/10 and Value-Trap risk of 30/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Bausch + Lomb Corporation (BLCO) in 2026?
What Is the Bull Case vs the Bear Case for Bausch + Lomb Corporation (BLCO)?
| Bull case — $37.76 target (+119.2%) | Bear case — $8.92 target (-48.2%) |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, 5 of 7 models identify upside from $17.23 to a median fair value of $23.33, indicating the market hasn't fully priced in Bausch + Lomb Corporation's earnings power. | According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $8.92 (-48.2%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $37.76 (+119.2%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +167.4% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
How Does BLCO Compare to Its Medical Instruments & Supplies Peers?
Valuation data pages: BAX · TFX · KRMD · RVP · MMED · MLSS · PLSE · WST · WRBY · ISRG · RMD
Which Other Stocks Score Like BLCO on Quality?
Closest companies to BLCO’s Quality of Company score of 6.3/10, across all industries.
- WPP — WPP plc (QOC 6.3) · analysis
- FLY — Firefly Aerospace Inc. (QOC 6.3) · analysis
- CATO — The Cato Corporation (QOC 6.3) · analysis
- FLG — Flagstar Bank, National Association (QOC 6.3) · analysis
- ALTG — Alta Equipment Group Inc. (QOC 6.3) · analysis
- AVBC — Avidia Bancorp, Inc. (QOC 6.3) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Instruments & Supplies Screens Does BLCO Appear In?
So Is Bausch + Lomb Corporation (BLCO) Worth Buying in 2026?
Bausch + Lomb Corporation leans positive in our analysis — 5/7 models bullish, median fair value of $23.33 vs. $17.23, QOC 6.3/10. The case is constructive but not overwhelming, and the 2 dissenting models shouldn't be dismissed. Position sizing should reflect this moderate conviction level.
These are quantitative model outputs, not investment recommendations. Bausch + Lomb Corporation's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About BLCO Stock?
Should I buy BLCO stock right now?
Based on CirclFi's multi-model analysis, 5 of 7 models see upside for BLCO at $17.23. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.3/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Bausch + Lomb Corporation?
Key risks include: limited model coverage (7/13 active), reducing analytical confidence; wide model disagreement (323% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.
How does BLCO compare to its competitors?
Among Medical Instruments & Supplies peers, BLCO holds a Quality Score of 6.3/10. Comparable companies include BAX (QOC 6.3), TFX (QOC 6.2), KRMD (QOC 6.5). The relative ranking helps investors identify whether BLCO offers better fundamental quality than alternatives in the same sector.
Is BLCO a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. BLCO's Quality Score of 6.3/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy BLCO at?
CirclFi does not provide target buy prices or price alerts. However, our 7 active models produce fair value estimates ranging from $8.92 to $37.76. At $17.23, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for BLCO.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad